Safety Study of Intravenous MiraMSC in Older Adults With Mild to Moderate Frailty Syndrome

NCT07705464 · clinicaltrials.gov ↗

PHASE1

Phase

NOT_YET_RECRUITING

Status

12

Enrollment

INDUSTRY

Sponsor class

Conditions

Frailty

Interventions

DRUG: MiraMSC-FS-001

Sponsor

Miracle Biomedical Co., Ltd.